West Lafayette, IN, United States of America

Fei Yu

This inventor holds 1 USPTO granted patent. Top assignee: Endocyte, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Yu. Retrieved from https://idiyas.com/inventor/fei-yu-r9gn0nns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fei Yu: Innovator in Targeted Drug Delivery

Introduction

Fei Yu is a notable inventor based in West Lafayette, Indiana, recognized for his contributions to the field of drug delivery systems. His innovative work focuses on developing targeted therapies to address inflammation-related diseases.

Latest Patents

Fei Yu holds a patent for "Vitamin receptor drug delivery conjugates for treating inflammation." This patent describes compositions, methods, compounds, conjugates, and kits designed for targeted drug delivery. The drug delivery conjugates utilize hydrophilic spacer linkers to effectively treat disease states caused by pathogenic cell populations, particularly inflammatory cells.

Career Highlights

Fei Yu is associated with Endocyte, Inc., a company dedicated to advancing targeted therapies. His work at Endocyte has positioned him as a key player in the development of innovative drug delivery systems.

Collaborations

Fei Yu collaborates with esteemed colleagues, including Christopher Paul Leamon and Iontcho Radoslavov Vlahov, contributing to a dynamic research environment focused on improving therapeutic outcomes.

Conclusion

Fei Yu's contributions to targeted drug delivery represent significant advancements in the treatment of inflammatory diseases. His innovative approaches continue to influence the field and pave the way for future developments in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…